Delivery Order SPE2DB22D1017-SPE2DB25FF0GE

Award Date 12/2/24
Potential Completion Date 12/3/24
Potential Value $6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FF0GE
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $5,994.65 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 4,566,582,930 units of Eliquis 5 mg tablets. The contract has a completion date of December 3, 2024 and utilizes a Firm Fixed Price pricing type. AmerisourceBergen, a for-profit organization registered in the System for Award Management (SAM.gov), holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999 through November 2026 to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs. This contract award does not have a set-aside designation, indicating open competition.

Generated 3/9/25, 12:51 AM